Management of solitary palatal metastasis from renal cell carcinoma

Nature Clinical Practice Urology

Volumn 3, Issue 7, 2006, Pages 392-396

  Kohli, Manish ^a,b   Schaefer, Robert ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; LIDOCAINE;

AGED; ARTICLE; ASPIRATION BIOPSY; BONE MARROW SUPPRESSION; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; DYSPHAGIA; FATIGUE; FOLLOW UP; HARD PALATE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAW CANCER; KIDNEY CARCINOMA; KIDNEY FAILURE; LOW DRUG DOSE; LUNG METASTASIS; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SOFT PALATE; SYSTEMIC DISEASE; TUMOR GROWTH;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; HUMANS; INTERFERON ALFA-2B; KIDNEY NEOPLASMS; MALE; PALATAL NEOPLASMS;

EID: 33745936912     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0536     Document Type: Article

References (15)

1. Susan LP et al. (1979) Palatal metastases in renal cell carcinoma. Urology 13: 304-305
2. Lutcavage GJ et al. (1984) Renal cell carcinoma metastasis to the hard palate. J Oral Maxillofac Surg 42: 469-474
3. Sabo R et al. (2001) Metastatic hypernephroma to the head and neck: unusual case reports and review of the literature. J Otolaryngol 30: 140-144
4. Pritchyk KM et al. (2002) Metastatic renal cell carcinoma to the head and neck. Laryngoscope 112: 1598-1602
5. Kozlowski JM (1994) Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites. Urol Clin North Am 21: 601-624
6. Flocks RH and Boatman DL (1973) Incidence of head and neck metastases from genito-urinary neoplasms. Laryngoscope 83: 1527-1539
7. Bennington JL and Kradjan RM (1967) Distribution of metastases from renal carcinoma: In Renal Carcinoma, 156-170. Philadelphia: WB Saunders
8. Negrier S et al. (1998) Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Francais d'Immunotherapie. N Engl J Med 338: 1272-1278
9. Fisher RI et al. (2000) Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. Cancer J Sci Am 1 (Suppl): S55-S57
10. Kavolius JP et al. (1998) Resection of metastatic renal cell carcinoma. J Clin Oncol 16: 2261-2266
11. Swanson DA (2004) Surgery for metastases of renal cell carcinoma. Scand J Surg 93: 150-155
12. Nakamoto T et al. (1997) Inhalation of interleukin-2 combined with subcutaneous administration of interferon for the treatment of pulmonary metastases from renal cell carcinoma. Int J Urol 4: 343-348
13. Wu WZ et al. (2005) Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways. J Cancer Res Clin Oncol 131: 169-178
14. Lindner DJ (2002) Interferons as antiangiogenic agents. Curr Oncol Rep 4: 510-514
15. Daniel L et al. (2003) Neural cell adhesion molecule expression in renal cell carcinomas: Relation to metastatic behavior. Hum Pathol 34: 528-532